Masanobu Shiga

7PUBLICATIONS
32CO-AUTHORS
Molecular targetsPredictive and prognostic markersInfant and child healthCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 14, 2026
Efficacy of Nivolumab in Chemotherapy-Resistant Mesothelioma of the Tunica Vaginalis Testis: A Case Report.

|Jun 17, 2026
Assessment of Multiple Prognostic Scores in Patients With Metastatic Renal Cell Carcinoma Receiving First-Line, Immune-Based Combinations.

|May 24, 2026
Adrenocortical Carcinoma in Peutz-Jeghers Syndrome With a Rare STK11 Pathogenic Germline Variant: A Case Report.

|May 07, 2026
Impact of European Association of Urology Combination and Platinum Eligibility on Real-World Treatment Sequences and Survival in Japanese Patients With Metastatic Urothelial Carcinoma.

|Jan 24, 2026
Outcomes and Management of Dermatologic Toxicity Following Enfortumab Vedotin Rechallenge in Patients With Metastatic Urothelial Carcinoma: A Retrospective Single-Center Study.

Takashi Kawahara, Yoshiyuki Nagumo, Akane Yamaguchi

|Sep 05, 2025
Prognostic Impact of Immune-Related Adverse Events on Combination Immune Checkpoint/Tyrosine Kinase Inhibition for Metastatic Renal Cancer.

Bunpei Isoda, Masanobu Shiga, Shuya Kandori

Pageof 2

Frequent Collaborators

7 joint publications

Shuya Kandori

5 joint publications

Akio Hoshi

4 joint publications

Takashi Kawahara

4 joint publications

Satoshi Nitta